Your browser doesn't support javascript.
loading
Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme.
DeVries, J Hans; Desouza, Cyrus; Bellary, Srikanth; Unger, Jeffrey; Hansen, Oluf K H; Zacho, Jeppe; Woo, Vincent.
Afiliação
  • DeVries JH; Department of Endocrinology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Desouza C; Profil Institute for Metabolic Research, Neuss, Germany.
  • Bellary S; Division of Diabetes Endocrinology & Metabolism, University of Nebraska Medical Center, Omaha, Nebraska.
  • Unger J; School of Life and Health Sciences, Aston University, Birmingham, UK.
  • Hansen OKH; Director, Metabolic Studies, Catalina Research Institute, Chino, California.
  • Zacho J; Novo Nordisk A/S, Søborg, Denmark.
  • Woo V; Novo Nordisk Pharma Ltd., Tokyo, Japan.
Diabetes Obes Metab ; 20(10): 2426-2434, 2018 10.
Article em En | MEDLINE | ID: mdl-29862621

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Hemoglobinas Glicadas / Aumento de Peso / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Gastroenteropatias Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Hemoglobinas Glicadas / Aumento de Peso / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Gastroenteropatias Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article